Evidence mapPaperPMID 42571485Full record

ReviewBioactive materials2027

Defining biomaterial-driven design principles for bioabsorbable flow diverters: current state and perspectives.

Alessandra Di Lorenzo, Amr F Mohamed, Benedetta Isella, Daniel Behme, Alexander Loewen, Mark Vekemans, Roland Schwab, Tara C Schmitz, Stefan Jockenhoevel, Alexander Kopp

Abstract readReview
In one paragraph

Review in Bioactive materials, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alessandra Di LorenzoFibrothelium GmbH, Triwo Technopark Aachen, Philipsstraße 8, Aachen, 52068, Germany.
Amr F MohamedEmbocraft GmbH, Triwo Technopark Aachen, Philipsstraße 8, Aachen, 52068, Germany.
Benedetta IsellaFibrothelium GmbH, Triwo Technopark Aachen, Philipsstraße 8, Aachen, 52068, Germany.
Daniel BehmeResearch Campus STIMULATE, Otto-von-Guericke University Magdeburg, Magdeburg, 39104, Germany.
Alexander LoewenDepartment of Biohybrid & Medical Textiles (BioTex), AME - Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, Aachen, 52074, Germany.
Mark VekemansEmbocraft GmbH, Triwo Technopark Aachen, Philipsstraße 8, Aachen, 52068, Germany.
Roland SchwabResearch Campus STIMULATE, Otto-von-Guericke University Magdeburg, Magdeburg, 39104, Germany.
Tara C SchmitzMedical Magnesium GmbH, Triwo Technopark Aachen, Philipsstraße 8, Aachen, 52068, Germany.
Stefan JockenhoevelDepartment of Biohybrid & Medical Textiles (BioTex), AME - Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, Aachen, 52074, Germany.
Alexander KoppFibrothelium GmbH, Triwo Technopark Aachen, Philipsstraße 8, Aachen, 52068, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flow diverters (FDs) have revolutionized intracranial aneurysm management, but current permanent metallic devices remain constrained by their bulk and surface properties, which induce chronic inflammation, thrombotic risk, and impaired vessel-wall integration. In this review we address these material-driven design challenges, examining how bioactive bioabsorbable biomaterials can overcome current limitations by balancing scaffold resorption with aneurysm occlusion. Moving beyond the clinical focus of existing literature, we establish a rational design roadmap bridging the gap between bulk material properties and FD architecture. We analyze how synchronized degradation kinetics and neointimal encapsulation govern device functionality, identifying this biological isolation as a necessary safety requirement to ensure resorption occurs only after the scaffold is shielded from the active flow. We analyze the mechanical-biological trade-offs of current platforms, whereby bioabsorbable polymers offer superior flexibility but limited radial support, whereas bioabsorbable metals provide higher mechanical integrity but require precision control over degradation. Hybrid strategies, combining transient and permanent components, emerge as effective solutions to balance mechanical reliability with controlled resorption. Across material classes, sustained flow diversion and vascular healing are primarily dictated by the interplay of scaffold architecture, material composition, and time-dependent surface evolution. Our analysis highlights that converging bulk material selection with advanced interfacial engineering enables the rational design of bioabsorbable FDs that maintain temporary mechanical integrity, while ensuring predictable aneurysm occlusion. These design principles establish a scientific framework for next-generation bioactive neurovascular implants, emphasizing a materials-driven approach to optimize safety and translational potential.

Indexed as

BioabsorbableBioactive coatingsEndothelializationFlow diverterMetalPolymer

Identifiers

PMID42571485
PMCPMC13452358

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.